findmyKOL
Clinical trialNCT05462106RecruitingPhase 1/PHASE2Interventional

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

SponsorAC Immune SAEnrollment304Alzheimer's DiseaseAmyloid PlaqueBeta-AmyloidDSADProdromal Alzheimer's Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Fundació Ace, Institut Català de Neurociències Aplicades

    Barcelona, Spain

    Recruiting
  • Hospital de la Santa Creu I Sant Pau

    Barcelona, Spain

    Recruiting
  • Hospital Universitario Virgen de Las Nieves

    Granada, Spain

    Withdrawn
  • Hospital Clínico San Carlos

    Madrid, Spain

    Recruiting
  • Hospital Universitario de la Princesa

    Madrid, Spain

    Active, not recruiting
  • Hospital Universitario Marqués de Valdecilla

    Santander, Spain

    Active, not recruiting
  • Hospital Universitario Y Politécnico la Fe

    Valencia, Spain

    Recruiting
United Kingdom
  • Cambridge and Peterborough Nhs Foundation Trust - Windsor Research Units

    Cambridge, United Kingdom

    Active, not recruiting
  • Liverpool University Hospitals Nhs Foundation Trust

    Liverpool, United Kingdom

    Recruiting
  • Re:cognition Health Limited

    London, United Kingdom

    Recruiting
  • South London and Maudsley Nhs Foundation Trust of the Maudsley Hospital

    London, United Kingdom

    Recruiting
  • Oxford Health Nhs Foundation Trust

    Oxford, United Kingdom

    Recruiting
  • Neuroclin Limited

    Warrington, United Kingdom

    Not, yet, recruiting
United States
  • Barrow Neurological Institute

    Phoenix, Arizona, United States

    Withdrawn
  • K2 Medical Research the Villages Llc

    Lady Lake, Florida, United States

    Recruiting
  • Charter Research, Llc

    Orlando, Florida, United States

    Recruiting
  • Headlands Horizons Llc

    Orlando, Florida, United States

    Not, yet, recruiting
  • Charter Research, Llc

    The Villages, Florida, United States

    Recruiting
  • Indiana University / Iu Health

    Indianapolis, Indiana, United States

    Active, not recruiting
  • University of Kansas Medical Center Research Institute

    Fairway, Kansas, United States

    Active, not recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, United States

    Active, not recruiting
  • the Washington University

    St Louis, Missouri, United States

    Active, not recruiting
  • Flourish Research

    Matthews, North Carolina, United States

    Not, yet, recruiting
  • Neurology Clinical, P.C.

    Cordova, Tennessee, United States

    Recruiting
  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

    Active, not recruiting
  • Ut Health San Antonio

    San Antonio, Texas, United States

    Withdrawn

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Jun 2022
Primary completion
30 Apr 2029
Completion
30 Apr 2029
Last update posted
10 Jul 2026
Registered enrollment
304
Registry id
NCT05462106

Cross-registrations

EU-CTR / CTIS (EudraCT)2021-006195-17EU-CTR / CTIS (EudraCT)2022-500069-29-00

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.